VANI

No price yet

Announcements

Nothing here yet

Daily updates

Nothing here yet

FDA designations

Nothing here yet

News

Vivani Medical entered an agreement with Novo Nordisk to evaluate a long-acting semaglutide implant for weight managementJul 8, 2026
Vivani Medical provides update on clinical development plans for NPM-139 semaglutide implant for chronic weight managementSep 4, 2025
Vivani Medical announces rapid advancement of NPM-139, a novel semaglutide implant, following positive weight loss data from ongoing preclinical study and promising results from LIBERATE-1 Phase 1 clinical study of NPM-115Aug 5, 2025